Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Saghmos Therapeutics Logo
Saghmos Therapeutics Growth Score
61
CB Rank
345436
Heat Score
49
Saghmos Therapeutics is a privately held biopharmaceuticals company with a Phase 3-ready cardiorenal metabolic modulator.
Founded
obfuscation
Private Greenwich, Connecticut, United States1-10 saghmos.com
Biotechnology
Medical
Medical Device
Pharmaceutical
Overview

Saghmos Therapeutics
Growth Score
61
Heat Score
49

Growth Score61
-3 pts
in past quarter
Heat Score 49
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Saghmos Therapeutics

CB Rank
345436
Saghmos Therapeutics is a privately held biopharmaceuticals company with a Phase 3-ready cardiorenal metabolic modulator.
Founded
obfuscation
Private Greenwich, Connecticut, United States1-10 saghmos.com
Biotechnology
Medical
Medical Device
Pharmaceutical

Key People

Details

Legal Name Saghmos Therapeutics Inc.
Operating Status Active
Company Type For Profit
Phone Number +1 914-522-3885
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Dec 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

2Saghmos Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 200m.

Total IP

4The intellectual property of Saghmos Therapeutics includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Saghmos Therapeutics's headquarters? Saghmos Therapeutics is located in Greenwich, Connecticut, United States.Who are Saghmos Therapeutics's competitors? Alternatives and possible competitors to Saghmos Therapeutics may include Eli Lilly, Pfizer, and  Roche.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|